๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mitomycin C treatment of advanced, hormone-resistant prostatic carcinoma: a phase II study

โœ Scribed by A. Veronesi; V. Dal Bo; G. Lo Re; M. Della Valentina; U. Tirelli; A. Merlo; R. Talamini; M. Francini; S. Monfardini

Publisher
Springer
Year
1989
Tongue
English
Weight
174 KB
Volume
23
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Chemotherapy for hormonally refractory a
Chemotherapy for hormonally refractory advanced prostate carcinoma. A Comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil
โœ John A. Laurie; Richard G. Hahn; Terry M. Therneau; Shreyaskumar R. Patel; James ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 398 KB ๐Ÿ‘ 2 views

One hundred forty-two patients with progressive, hormonally refractory advanced prostate carcinoma who had not received prior chemotherapy were randomized to receive either combination chemotherapy with 5-fluorouracil(5-FU), doxorubicin, and mitomycin C (FAM) or sequential chemotherapy with the same

A phase II trial of 5-fluorouracil, doxo
A phase II trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma
โœ Susan G. Arbuck; Yusuf Silk Md; Harold O. Douglass Jr.; Hector Nava; Youcef M. R ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 363 KB ๐Ÿ‘ 2 views

To determine the feasibility and toxicity of combining leucovorin (CF) with a 5fluorouracil(5-FU) combination chemotherapy regimen currently accepted by many as standard treatment for gastric cancer, CF (500 mg/m') was administered in combination with the Georgetown S-FU, doxorubicin, and mitomycin